Toft Group Completes Executive Search for OPKO Health, Inc. (Nasdaq: OPK) in Miami, FL
Executive search firm Toft Group has placed Mr. Thomas Nusbickel, MBA as Senior Vice President, Marketing and Market Access at OPKO Health, Inc. in Miami, FL. Mr. Nusbickel is a seasoned pharmaceutical executive with 12 years of experience commercializing nephrology products, and 25+ years of experience in specialty pharmaceuticals. He most recently served as Head, US Market Access, Biologics at Hospira, Inc. in Lake Forest, IL.
About OPKO Health, Inc.
OPKO Health, Inc. is a diversified healthcare company that seeks to establish industry-leading positions in large, rapidly growing markets. Our diagnostics business includes Bio-Reference Laboratories, the nation's third-largest clinical laboratory with a core genetic testing business and a 420-person sales force to drive growth and leverage new products, including the 4Kscore® prostate cancer test and the Claros®1 in-office immunoassay platform. Our pharmaceutical business features RAYALDEE, a treatment pending FDA approval for SHPT in stage 3-4 CKD patients with vitamin D insufficiency, and VARUBI™ for chemotherapy-induced nausea and vomiting (oral formulation approved by FDA and launched by partner Tesaro, IV formulation in Phase 3). Our biologics business includes hGH-CTP, a once-weekly human growth hormone injection (in Phase 3 and partnered with Pfizer), and a long-acting Factor VIIa drug for hemophilia (entering Phase 2a). We also have production and distribution assets worldwide, multiple strategic investments and an active business development strategy.